Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MULTIPLE NAME

K-Number: K123819 · 2013-03-05

Decision Date2013-03-05
Product CodeLYY
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

MULTIPLE NAME is the device name listed in this FDA 510(k) record. The listed applicant is Top Calibre Sdn Bhd. It received FDA 510(k) clearance on 2013-03-05 under 510(k) number K123819. The device is classified under product code LYY. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MULTIPLE NAME?

MULTIPLE NAME is a medical device that received FDA 510(k) clearance on 2013-03-05. The listed applicant is Top Calibre Sdn Bhd. The 510(k) number is K123819.

When did MULTIPLE NAME receive FDA 510(k) clearance?

MULTIPLE NAME received FDA 510(k) clearance on 2013-03-05, under 510(k) number K123819.

Who is the listed applicant for MULTIPLE NAME?

The FDA 510(k) record lists Top Calibre Sdn Bhd as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MULTIPLE NAME?

The FDA product code for MULTIPLE NAME is LYY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Top Calibre Sdn Bhd as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LYY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑